Overview
LMRI market data
Price History
LMRI price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.49 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.24 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.45 – $19.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.1B · P/B 2.83 · P/S 0.88.
Company News
Lumexa Imaging Holdings Affirms FY2026 Adj EPS Guidance of $0.71-$0.77 vs $0.62 Est; Raises FY2026 Sales Guidance from $1.045B-$1.090B to $1.045B-$1.097B vs $1.067B EstBenzinga · Aug 12, 2026, 8:08 PM
Lumexa Imaging Holdings Q2 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $264.200M Beat $263.113M EstimateBenzinga · Aug 12, 2026, 8:08 PM
8-K filing — Lumexa Imaging Holdings, Inc. (LMRI)SEC EDGAR · Jun 30, 2026, 9:08 PM
Lumexa Imaging Forms Strategic JV With Hospital For Special Surgery To Expand Access To Advanced Outpatient Imaging Services Across New York City Metro AreaBenzinga · Jun 2, 2026, 11:14 AM
Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9Benzinga · May 20, 2026, 2:00 PM